Master of Translational Medicine
Craniofacial deformities are among the most common birth defects in the U.S. yet treatment often involves delayed, invasive surgery. FaceShift is developing customizable, noninvasive devices to offer earlier, more accessible care.
Nexocura is developing a novel, non-surgical treatment to help bone fractures heal faster and more effectively, potentially impacting recovery for millions of fracture patients.
The IVVA capstone team is advancing telemedicine by developing software to measure vital signs from standard video, enhancing remote clinical assessment without extra hardware.
MTM students colaborate with the UCSF Sarwal Lab to develop a novel nanoparticle-delivered therapy for Nephropathic Cystinosis to prevent end-stage renal disease in children.
The FaceShift capstone team is revolutionizing surgical planning for craniofacial deformities, leveraging 3D printing and advanced imaging to create patient-specific models.
Meet Dr. Shuvo Roy, a pioneer in the field of bioengineering and the lead behind The Kidney Project, inspiring the next generation of MTM innovators.
Congenital heart disease treatment is going non-surgical. The IntelliStent team is developing a smart endovascular stent, a treatment that avoids invasive open-heart surgery.
NextSense is exploring digital, wearable interventions to manage ADHD, using data-driven insights to deliver personalized, non-drug support for neurodivergent individuals.
Meet Verna Rodriguez, MTM Program Director, and discover her vision for growth and commitment to uniting engineers and clinicians to solve major medical challenges.
See how our “Lean Transfer” curriculum teaches rapid prototyping, regulatory navigation, and market validation to move medical devices from lab to clinic—and to patients.
Launching a new Therapeutics Track in 2024: deep training in drug discovery, clinical trials, and pharmaceutical regulatory strategy.